Hasil Pencarian - Shi‐Yong Sun
- Menampilkan 1 - 20 hasil dari 25
- Ke Halaman Berikutnya
-
1
Searching for the real function of mTOR signaling in the regulation of PD-L1 expression oleh Shi-Yong Sun
Diterbitkan 2020-12-01
Artikel -
2
Editorial: Challenges and opportunities of TKIs in the treatment of NSCLC patients with uncommon mutations oleh Chunxia Su, Shi-Yong Sun
Diterbitkan 2022-07-01
Artikel -
3
Regulation of Cancer Metastasis by TRAIL/Death Receptor Signaling oleh You-Take Oh, Shi-Yong Sun
Diterbitkan 2021-03-01
Artikel -
4
-
5
-
6
Inhibition of p70S6K does not mimic the enhancement of Akt phosphorylation by rapamycin oleh Xuerong Wang, Ping Yue, Hui Tao, Shi-Yong Sun
Diterbitkan 2017-08-01
Artikel -
7
MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer oleh Qiming Wang, Sen Yang, Kai Wang, Shi-Yong Sun
Diterbitkan 2019-06-01
Artikel -
8
-
9
-
10
The eIF4E/eIF4G Interaction Inhibitor 4EGI-1 Augments TRAIL-Mediated Apoptosis through c-FLIP Down-regulation and DR5 Induction Independent of Inhibition of Cap-Dependent Protein T... oleh Songqing Fan, Yikun Li, Ping Yue, Fadlo R. Khuri, Shi-Yong Sun
Diterbitkan 2010-04-01
Artikel -
11
Mono- or double-site phosphorylation distinctly regulates the proapoptotic function of Bax. oleh Qinhong Wang, Shi-Yong Sun, Fadlo Khuri, Walter J Curran, Xingming Deng
Diterbitkan 2010-10-01
Artikel -
12
-
13
-
14
-
15
Protein Phosphatase 2A Negatively Regulates Eukaryotic Initiation Factor 4E Phosphorylation and eIF4F Assembly through Direct Dephosphorylation of Mnk and eIF4E oleh Yikun Li, Ping Yue, Xingming Deng, Takeshi Ueda, Rikiro Fukunaga, Fadlo R. Khuri, Shi-Yong Sun
Diterbitkan 2010-10-01
Artikel -
16
Corrigendum to “Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E” [N... oleh Yikun Li, Ping Yue, Xingming Deng, Takeshi Ueda, Rikiro Fukunaga, Fadlo R Khuri, Shi-Yong Sun
Diterbitkan 2024-10-01
Artikel -
17
Overcoming acquired resistance of EGFR‐mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib, with the natural product honokiol oleh Hongjing Zang, Guoqing Qian, Jack Arbiser, Taofeek K. Owonikoko, Suresh S. Ramalingam, Songqing Fan, Shi‐Yong Sun
Diterbitkan 2020-04-01
Artikel -
18
The Third-Generation EGFR Inhibitor, Osimertinib, Promotes c-FLIP Degradation, Enhancing Apoptosis Including TRAIL-Induced Apoptosis in NSCLC Cells with Activating EGFR Mutations oleh Puyu Shi, Shuo Zhang, Lei Zhu, Guoqing Qian, Hui Ren, Suresh S. Ramalingam, Mingwei Chen, Shi-Yong Sun
Diterbitkan 2019-05-01
Artikel -
19
-
20
The combination of RAD001 and NVP-BEZ235 exerts synergistic anticancer activity against non-small cell lung cancer in vitro and in vivo. oleh Cheng-Xiong Xu, Yikun Li, Ping Yue, Taofeek K Owonikoko, Suresh S Ramalingam, Fadlo R Khuri, Shi-Yong Sun
Diterbitkan 2011-01-01
Artikel